Keratoconus in children: progression comes first
Pediatric keratoconus behaves differently from adult disease.
- More advanced at diagnosis. In a French national reference center study, 27.8% of patients aged 15 or younger were stage 4 at diagnosis, versus 7.8% of adults. When keratoconus progressed after diagnosis, it progressed faster in children.[1]
- Harder to manage. A 2023 review lists delayed presentation of unilateral disease, more advanced disease at diagnosis, difficulty obtaining reliable imaging, faster progression, and challenges in contact lens management.[2]
- Visual development. A 2026 European consensus statement describes pediatric keratoconus as often advancing rapidly and significantly affecting visual development.[3]
The KERALINK randomized trial enrolled 60 patients aged 10 to 16 with progressive keratoconus. At 18 months, mean steep keratometry was 49.7 D in the CXL group and 53.4 D with standard care, an adjusted difference of 3.0 D favoring CXL. Progression occurred in 7% of patients after CXL and 43% with standard care, which included spectacles or contact lenses as needed.[4] The authors recommend CXL be considered first-line in progressive disease.[4]
In adults too, lenses don’t stop ectasia: in a keratoconus scleral lens series, 14.6% of eyes lost best-corrected lens acuity, all from progression.[10]
Practical sequence for a child or teen with keratoconus: obtain baseline tomography, refer for CXL evaluation promptly if there is progression or high risk, and refer for lens fitting when spectacles no longer give adequate acuity. The two referrals can run together, and the fitter needs the tomography history.
What pediatric scleral lens series show
Most published pediatric scleral lens experience is in ocular surface disease, not keratoconus.
- Boston, 1996 to 2006 (47 eyes, 31 patients under 13): ages ranged from 7 months to 12.92 years. 87% of patients were fit for ocular surface disease and 13% for refractive disorders. Congenital corneal anesthesia syndromes and Stevens-Johnson syndrome each accounted for over a third of patients. All were referred after failure of conventional therapy.[5]
- Boston, 21-year review (209 eyes): 147 eyes had ocular surface disease and 62 had irregular cornea or refractive conditions. Mean age at the start of treatment was 10.6 years. At last review, 70% of eyes were still wearing lenses (mean duration 8.2 years), 8% had discontinued, and status was unknown for 22%. Mean logMAR acuity improved from 0.93 at presentation to 0.43 in lenses. Application and removal challenges were the main reason for discontinuation.[6]
- SJS/TEN, PROSE (49 patients 18 or younger): median acuity improved from 20/80 at presentation to 20/30 at device dispense and remained 20/30 at last visit (mean follow-up 5.45 years). 30.6% failed treatment.[7]
- India, quality of life (25 eyes): in keratoconus, ocular surface disease, and corneal tear repair, median acuity improved from 0.50 logMAR in spectacles to 0.10 in lenses after one month, with significant gains in the child’s and the parents’ quality of life.[8]
These are single-center, mostly retrospective series from experienced centers, with no comparison groups.
Pediatric indications to consider
- Keratoconus and other ectasias where spectacles fail, alongside CXL evaluation
- Stevens-Johnson syndrome / TEN with chronic surface disease[7]
- Neurotrophic keratopathy, including congenital corneal anesthesia[5]
- Exposure keratopathy[6]
- Corneal scarring and post-traumatic irregularity, including after corneal laceration repair[8]
What makes a pediatric fit work
- A trained caregiver. A review states there are no age restrictions and that parents or caregivers may be trained to assist with application and removal.[9] In the 21-year review, the center added clinic time for pediatric visits, involved parents in application and removal, and assessed whether a parent or the patient could manage it before treatment.[6]
- Realistic expectations about handling. Application and removal problems were the main reason children stopped.[6]
- Room to grow. In the 21-year review, mean lens diameter increased significantly over follow-up, from 17.7 mm initially to a mean final diameter of 18.2 mm, and the authors concluded larger diameters were not an obstacle for children.[6] Plan for refits.
- Parental quality of life matters too. The improvement in parents’ quality of life led one group to recommend making caregiver compliance a priority.[8]
What to send with a pediatric referral
In addition to the standard checklist:
- all tomography to date, even if imaging quality was limited
- CXL status and the treating surgeon
- amblyopia history and current treatment
- atopy and eye-rubbing history
- who will handle the lenses at home, and any school or activity considerations
Common questions
Is a child too young for scleral lenses?
The literature reviewed here sets no lower limit. A Boston series fitted patients from 7 months to just under 13 years, and a review states there are no age restrictions, with parents or caregivers trained to apply and remove the lens.
Should a teenager with keratoconus get CXL or scleral lenses?
Usually the question is both, in that order of urgency. CXL addresses progression and lenses address vision. In the KERALINK trial of 10- to 16-year-olds, standard care with spectacles or contact lenses did not prevent progression in 43% of patients over 18 months.
Who inserts the lens for a young child?
Usually a parent or caregiver, trained by the fitter. In a 21-year pediatric review, parents were involved in the application and removal process, and extra clinic time was scheduled for pediatric visits.